Surprising Ozempic Side Effects You Need To Know About, According To A Doctor

Ozempic’s side effects are getting nearly as much attention as the drug itself (maybe you’ve heard of Ozempic’s face). Intended for those with type 2 diabetes, Ozempic (which lists semaglutide as the main active ingredient) is an injectable drug that helps manage blood sugar. . The drug, which is part of a glucagon-like peptide 1 … Read more

Dupilumab is the first investigational biologic to significantly improve lung function in COPD patients

Dupilumab (Dupixent; Sanofi) is the first and only investigational biologic to significantly improve lung function at 12 and 52 weeks and significantly reduce severe acute exacerbations compared with placebo in adults with chronic obstructive pulmonary disease (COPD), according to the authors. presented a positive Phase 3 best outcome at the 2023 American Thoracic Society (ATS) … Read more

FDA approves Yuflyma as Adalimumab’s ninth biosimilar

The US Food and Drug Administration (FDA) has approved the biosimilar adalimumab-aaty (Yuflyma) in a highly concentrated citrate-free formulation, the manufacturer, Celltrion USA, announced today. It is the ninth biosimilar of adalimumab (Humira) to be approved in the United States. Yuflyma is approved for the treatment of adult patients with rheumatoid arthritis, psoriatic arthritis, ankylosing … Read more

Women at higher risk of inflation-related stress

Rising inflation is causing significant stress in the US population, particularly among women and socioeconomically vulnerable people, a new study indicates. An examination of US Census Bureau survey data found that after adjusting for socioeconomic status (SES), the risk of inflation stress was 28 percent higher among women than among men. However, it is unclear … Read more

Using artificial intelligence to discover new rapamycin-like molecules

In a recent article published in International journal of medical sciencesthe researchers described how they used artificial intelligence and machine learning tools to find molecules that inhibit mTOR [1]. mTOR is a common target for lifespan extension interventions Mechanistic target of rapamycin (mTOR) is a well known molecule in the world of rejuvenation. Previous studies … Read more

Chronic cannabis use increases the risk of major depression and bipolar disorder up to FOUR TIMES

Chronic cannabis use significantly increases the risk of mental health problems and personality disorders, suggests a major study. Research of more than 6.6 million people in Denmark found that those who were addicted to marijuana were up to four times more likely to be diagnosed with major depression or bipolar disorder. They looked at people … Read more

Medical group challenges FDA action to limit use of COVID-19 drugs

Case problem After the FDA issued an Emergency Use Authorization (EUA) for a COVID-19 drug but restricted its use to hospitalized patients, the Association of American Physicians and Surgeons (AAPS) launched a legal challenge. Has it prevailed? Credit: renaschild – stock.adobe.com Case facts From March 28 to June 15, 2020, the FDA issued an EUA … Read more

NCAA Study: Sports Betting Prevalent Among Young Adults Amid Rise in Advertising

Amid growing concerns about the prevalence of sports betting on college campuses, an NCAA a survey of 3,527 young people between the ages of 18 and 22 found that 58% had engaged in at least one sports betting activity. Charlie Baker he commissioned the poll weeks after he took office as NCAA president.Opinion diagnostics conducted … Read more

Scientists discover chemical that could help heal nerve damage A potential breakthrough for patients with paralysis

Updated May 24, 2023, 1:29 pm EDT Top line Scientists have discovered a new chemical that could help heal nerve damage, according to research published Wednesday in the journal Naturewhich offers initial hope for one day to reverse the paralysis and lost functioning that can result from nerve injury. help regenerate nerve cells. getty Main … Read more